Process for preparation of pharmaceutically desired enantiomers
AssigneeUop LLC
InventorMark J. Gattuso
Life of this patent
Estimating the term…
Abstract
Improved processes for preparation of high enantiomeric purity compounds center on resolution using simulated moving bed chromatography of a racemic precursor early in the synthesis. Resolution is effected with high enantiomeric purity, and subsequent reactions of the desired enantiomer performed with high optical specificity to maintain enantiomeric purity. The undesired enantiomer is racemized and recycled to the resolution phase to avoid loss.
Claims4
In a process for producing one enantiomer of a product compound wherein a racemic reactant is resolved into a first enantiomer of at least 95 % enantiomeric purity and a second enantiomer and the first enantiomer is selectively converted to the product compound, the improvement comprising:
- resolving the racemic reactant, in a resolution stage, by simulated moving bed chromatography using a chiral adsorbent to afford the first enantiomer of at least 95% enantiomeric purity and the second enantiomer, racemizing the second enantiomer to the racemic reactant, and recycling the racemic reactant to the resolution stage.
In a process for producing one enantiomer of a product compound wherein at least two racemic reactants are each resolved into a first enantiomer of at least 95% enantiomeric purity and a second enantiomer and the first enantiomer of each is used in the conversion to the product compound, the improvement comprising:
- resolving each racemic reactant, in a resolution stage, by simulated moving bed chromatography using a chiral adsorbent to afford the first enantiomer of at least 95% enantiomeric purity for each reactant and the second enantiomer for each reactant, racemizing the second enantiomers to the racemic reactants, and recycling the racemic reactants to the resolution stage.
Dependencies are inferred from the claim text.